Robert C. Wilson, III, & Maureen O. Hackett Elected Chairs of Menninger Boards

Tuesday, July 9, 2013
Menninger welcomes new leaders of its governing board and foundation board. Elected in June were Robert C. Wilson, III, chair of The Menninger Clinic Board of Directors that governs the national psychiatric hospital, and Maureen Hackett, chair of The Menninger Clinic Foundation Board of Directors that supports Menninger’s charitable mission for mental health. Both boards of directors include local, regional and national representation.
“Rob and Maureen are widely known as dedicated leaders and passionate mental health advocates. We are fortunate that they will be leading our two boards as we expand the reach of The Menninger Clinic and pursue vital advancements to improve mental health in this country and beyond,” said Ian Aitken, Menninger’s president and chief executive officer.
wilson-rob-2-2012-copyMr. Wilson has served 10 years on The Menninger Clinic and The Foundation Boards, chairing The Foundation Board for the past five years. He has also served on various committees, most notably chairing the Epicenter Architectural committee since 2005. In this role Mr. Wilson guided the organization’s property search and purchase of nearly 50 acres near South Post Oak Road and Main, and construction of The Mental Health Epicenter. Menninger moved into The Epicenter in 2012.
“I’m most proud of leading the planning and development of the 50-acre Epicenter campus,” Mr. Wilson said. “Now, as chair of The Clinic Board, I look forward to doing much more as we expand The Epicenter to continuously improve mental health services.”
Mr. Wilson succeeds John McKelvey, Leawood, Kan., who chaired the Menninger governing board for the past 10 years.
Mr. Wilson leads a number of real estate development and investment companies and serves as president of The John M. O’Quinn Foundation’s Board of Trustees. For Menninger’s affiliate, Baylor College of Medicine, Mr. Wilson was a member of the steering committee for the $1 Billion Building Fund Campaign that concluded in 2012. He is a University of Texas graduate with a degree in finance and is past vice chairman of Mental Health America of Greater Houston’s Board of Directors.
maureen-hackett-headshotMrs. Hackett succeeds Mr. Wilson as chair of The Menninger Clinic Foundation Board, which includes 30 Directors from Texas and other states who raise visibility for Menninger’s mission as well as support fund development for Menninger’s capital, research, training and annual fund priorities. As Foundation Board chair, she also has a position on the governing board, where she has been a Director and committee chair since 2010.
Mrs. Hackett is currently chair or past chair of several nonprofit organizations, including the Nantucket Cottage Hospital Foundation, Indiana University Lilly Family School of Philanthropy, Mental Health Court Foundation and Mental Health America of Greater Houston. She also serves on numerous local and national advisory boards, specializing in governance, strategic planning, development, community outreach and board development.
Mrs. Hackett and her family have supported many philanthropic projects and have brought mental illness into the forefront of public conversation through numerous endeavors. Recently, Mrs. Hackett partnered with the Greater Houston Community Foundation to establish a fund focusing on mental wellness through education, research, treatment and the eradication of stigma. In 2012, the Houston chapter of the American Fundraising Professionals named her the recipient of the Maurice Hirsch Award for Philanthropy.

The Menninger Clinic was founded in 1925 in Kansas and relocated to Houston in 2003, affiliating with Baylor College of Medicine and The Methodist Hospital. As a national psychiatric hospital, Menninger’s mission is to be a leader in mental health treatment, research and education. Menninger is located at 12301 S. Main St. on a nearly 50-acre campus that is home to a 120-bed inpatient hospital, training programs for mental health professionals and growing research in areas such as treatment of suicidality and biomarkers for psychiatric and addictive disorders.